AGROTON PUBLIC LIMITED INTERIM

Financial Statements

3 AGROTON PUBLIC LIMITED CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME For the six months ended 30 June 2019 (in USD thousand, unless otherwise stated) Note 30 June 2019 30 June 2018 Continuing operations Revenue 4 17 849 16 624 Cost of sales 5 (19 653) (16 045) Net change in fair value less cost to sell of biological assets and agricultural produce 5 697 8 271 Gross profit 3 893 8 850 Other operating income 6 78 695 Administrative expenses 7 (2 334) (1 726) Distribution expenses 8 (451) (1 004) Other operating expenses 9 (988) (849) Operating profit 198 5 966 Impairment losses on loans, trade and other receivable (86) (196) 112 5 770 Finance income 10 4 594 6 248 Finance costs 10 (1 429) (223) Net finance income 3 165 6 025 Profit before taxation 3 277 11 795 Taxation - - Profit for the period 3 277 11 795 Other comprehensive income Items that are or may be reclassified subsequently to profit or loss Effect of translation into presentation currency (368) (817) Total comprehensive income/(expense) 2 909 10 978 Profit attributable to: Owners of the Company 3 279 11 789 Non-controlling interests (2) 6 3 277 11 795 Total comprehensive income attributable to: Owners of the Company 2 904 10 964 Non-controlling interests 5 14 2 909 10 978 Profit per share Basic and fully diluted profit per share (USD) 0,13 0,51 Profit per share – continuing operations Basic and fully diluted profit per share (USD) 0,13 0,51 The notes on pages 8 to 33are an integral part of these condensed consolidated interim financial statements. AGROTON PUBLIC LIMITEI) ,4s at JQ Jpnp 2019 (in USD thousand, unless otherwise stated) Note 31 December 30 June 2019 2018 ASSets Property, plant and equipment ll t6 349 14 132 Right-of-use assets t2 15 552 Intangible assets 3.1 44 3 694 Biological assets l3 | 715 | 452 Total non-current assets 33 660 19 278 Inventories t6 tl 290 24 289 Biological assets l3 28 327 8 777 Investments designated at fair value through profit or loss l4 9 221 141 Trade and other receivables l7 5 429 Loans receivable l5 17 010 t6 274 Assets held for sale 18 l7 Cash and cash equivalents 18 8 198 24 881 Total current assets 77 287 79 808 Total assets ttO 947 99 086 Equity Share capital 661 661 Share premium 88 532 88 532 Retained earnings (10 157) (e 783) Foreign currency translation reserve 8 043 8 418 Total equity attributable to owners of t